We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Search
Filters
9068 Results

Journal Article

Corrigendum to “Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging” [Radiother Oncol 113 (2014) 324–30]
Authors: Emmanuel Rios Velazquez, Frank Hoebers, Hugo J.W.L. Aerts, Michelle M. Rietbergen, Ruud H. Brakenhoff, René C. Leemans, Ernst-Jan Speel, Jos Straetmans, Bernd Kremer, Philippe Lambin
2017
Radiotherapy and Oncology

Journal Article

A multicentre ‘end to end’ dosimetry audit of motion management (4DCT-defined motion envelope) in radiotherapy
Authors: Antony L. Palmer, David Nash, John R. Kearton, Shakardokht M. Jafari, Sarah Muscat
2017
Radiotherapy and Oncology

Congress Abstract

Factors preventing H&N patients starting post-operative radiotherapy within 6 weeks of surgery
Authors:

Shelly English1, Sabina Khan2, Anna Thompson3, Nicky Gilbody4, Atia Khan3

1North Middlesex University Hospital, Radiotherapy, London, United Kingdom; 2University College London Hospital , Radiotherapy, London, United Kingdom; 3North Middlesex University Hospital, Oncology, London, United Kingdom; 4North Middlesex University Hospital, Speech and Language Therapy , London, United Kingdom

Show Affiliations
2022
Poster
ICHNO–ECHNO 2022

Journal Article

International consensus recommendations for target volume delineation specific to sacral metastases and spinal stereotactic body radiation therapy (SBRT)
Authors: Emma M. Dunne, Arjun Sahgal, Simon S. Lo, Alanah Bergman, Robert Kosztyla, Nicolas Dea, Eric L. Chang, Ung-Kyu Chang, Samuel T. Chao, Salman Faruqi, Amol J. Ghia, Kristin J. Redmond, Scott G. Soltys, Mitchell C. Liu
2020
Radiotherapy and Oncology

Journal Article

Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac – Feasibility, workflow data and patient acceptance
Authors: Cihan Gani, S. Boeke, H. McNair, J. Ehlers, M. Nachbar, D. Mönnich, A. Stolte, J. Boldt, C. Marks, J. Winter, Luise A. Künzel, S. Gatidis, M. Bitzer, D. Thorwarth, D. Zips
2021
Clinical and Translational Radiation Oncology

Journal Article

GEC-ESTRO/ACROP recommendations for performing bladder-sparing treatment with brachytherapy for muscle-invasive bladder carcinoma
Authors: Bradley R. Pieters, Elzbieta van der Steen-Banasik, Geert A. Smits, Marisol De Brabandere, Alberto Bossi, Erik Van Limbergen
2017
Radiotherapy and Oncology

Congress Abstract

Dose guided surgery and its impact on the surgical management of mandibular osteoradionecrosis
Authors:

Nick West1, Nick Willis1, James Adams2, Matthew Kennedy2, Glyndwr Jenkins2, Muhammad Shahid Iqbal1, Zoë Davidson1

1Newcastle upon Tyne Hospitals Trust, Northern Centre for Cancer Care, Newcastle upon Tyne, United Kingdom; 2Newcastle upon Tyne Hospitals Trust, Surgery, Newcastle upon Tyne, United Kingdom

Show Affiliations
2021
Poster
ESTRO 2021

Journal Article

How to evaluate agreement between quantitative measurements
Authors: Annette Kopp-Schneider, Thomas Hielscher
2019
Radiotherapy and Oncology

Congress Abstract

Effects of proton vs photon irradiation on inflammation and senescence in salivary gland organoids
Authors:

Davide Cinat1,2, Lara Barazzuol1,2, Rob Coppes1,2

1University Medical Center Groningen, Department of Biomedical Sciences of Cells & Systems, Groningen, The Netherlands; 2University Medical Center Groningen, Department of Radiation Oncology, Groningen, The Netherlands

Show Affiliations
2021
Oral
ESTRO 2021

Congress Abstract

Modulations of salivary microbiota during radiotherapy for head and neck cancer

Authors:

Eliana Gioscio1, Nicola Alessandro Iacovelli2, Rossana Ingargiola2, Anna Cavallo3, Loris De Cecco4, Salvatore Alfieri5, Paolo Bossi5, Nadia Facchinetti2, Mara Serena Serafini6, Andrea Devecchi6, Cristina Bergamini7, Fabio Badenchini8, Tiziana Rancati1, Riccardo Valdagni8,9,10, Ester Orlandi9,2

1Fondazione IRCCS Istituto Nazionale dei Tumori, Prostate Cancer Program, Milan, Italy; 2Fondazione IRCCS Istituto Nazionale dei Tumori, Radiation Oncology 2, Milan, Italy; 3Fondazione IRCCS Istituto Nazionale dei Tumori, Medical Physics, Milan, Italy; 4Fondazione IRCCS Istituto Nazionale dei Tumori, Platform of Integrated Biology, Department of Applied Research and Technology Development, Milan, Italy; 5Fondazione IRCCS Istituto Nazionale dei Tumori, Medical Oncology 3, Milan, Italy; 6Fondazione IRCCS Istituto Nazionale dei Tumori, Platform of Integrated Biology, Department of Applied Research and Technology Development, Milan, Italy; 7Fondazione IRCCS Istituto Nazionale dei Tumori, Medical Oncology 3, Milan, Italy; 8Fondazione IRCCS Istituto Nazionale dei Tumori, Prostate Cancer Program, Milan, Italy; 9Fondazione IRCCS Istituto Nazionale dei Tumori, Radiation Oncology 1, Milan, Italy; 10Università degli Studi di Milano, Department of Oncology and Hemato-Oncology, Milan, Italy

Show Affiliations
2021
Poster highlight
ESTRO 2021
*:*